Redmond Asset Management, LLC Inhibikase Therapeutics, Inc. Transaction History

Redmond Asset Management, LLC

  • $304 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$0.45 - $0.78 $1,497 - $2,595
3,328 Added 2.72%
125,805 $62,000
Q3 2022

Nov 10, 2022
SELL
$0.76 - $1.11 $155 - $227
-205 Reduced 0.17%
122,477 $111,000
Q1 2022

May 03, 2022
BUY
$1.03 - $1.77 $126,362 - $217,147
122,682 New
122,682 $182,000

Others Institutions Holding IKT

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Inhibikase Therapeutics, Inc.

IKT Quotes by TradingView
  • Ticker IKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,227,100
  • Market Cap $33.8M
  • Description
  • Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointes...
More about IKT
Track This Portfolio

Track Redmond Asset Management, LLC Portfolio

Follow Redmond Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmond Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email